Mo. Appeals Court Upholds $38 Million Depakote Birth Defect Verdict



DOCUMENTS
  • Opinion


ST. LOUIS — A Missouri appeals court has upheld a $38 million verdict issued in favor of a girl who was born with spina bifida and other birth defects after being exposed to Depakote in utero, finding the evidence supported the jury’s finding that Abbott Laboratories failed to adequately warn doctors that the drug had an increased risk of birth defects versus its competitors and was significantly more dangerous for use in women of childbearing age.

On Nov. 8, the Missouri Court of Appeals, Eastern District, further found the evidence supported the jury’s determination that Abbott’s focus on profit motivated …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

June 13, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin’s Webinar Series: Update on Exactech Hip, Knee and Ankle Recall Litigation

June 15, 2022 - None, None
None

MORE DETAILS